Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Tables)

v3.2.0.727
STOCKHOLDERS' DEFICIT (Tables)
 9 Months Ended
Jun. 30, 2015
Stockholders Deficit Tables  
Schedule of stock-based compensation expense

Stock-based compensation expense included in the accompanying statements of operations for the three months and nine months ended June 30, 2015 and 2014 is as follows:

   

    For the three months ended
June 30,		  
    2015     2014  
Cost of Neurometric Services revenues   $ -     $ -  
Research     10,400       8,200  
Product Development     9,200       55,700  
Sales and marketing     9,100       21,300  
General and administrative     13,700       87,400  
Total   $ 42,400     $ 172,600  

 

    For the nine months ended
June 30,		  
    2015     2014  
Cost of Neurometric Services revenues   $ -     $ 5,100  
Research     31,200       55,100  
Product Development     43,200       193,900  
Sales and marketing     72,500       72,300  
General and administrative     57,800       513,300  
Total   $ 204,700     $ 839,700  

 
Schedule of stock option activity

A summary of stock option activity is as follows: 

 

    Number of 
Shares		     Weighted Average 
Exercise Price		  
Outstanding at September 30, 2014     12,417,499     $ 0.84  
Granted                
Exercised                
Forfeited                
Outstanding at December 31, 2014     12,417,499     $ 0.84  
Granted     250,000       0.25  
Exercised     -       -  
Forfeited     -       -  
Outstanding at March 31, 2015     12,667,499     $ 0.83  
Granted     -       -  
Exercised     -       -  
Forfeited     (48,608 )     0.04718  
Outstanding at June 30, 2015     12,618,891     $ 0.83  
Schedule of the status of options outstanding

Following is a summary of the status of options outstanding at June 30, 2015:

 

Exercise
Price		     Number
of Shares		     Expiration
Date		   Weighted Average
Exercise Price		  
                   
$ 0.04718       8,871,692     12/2022 – 01/2023   $ 0.04718  
$ 0.25       2,777,605     03/2023 – 01/2025     0.25  
$ 0.26       425,000     07/2024     0.26  
$ 3.00       42,670     03/2022     3.00  
$ 3.60       28,648     08/2016     3.60  
$ 3.96       32,928     08/2016     3.96  
$ 9.00       4,525     11/2016     9.00  
$ 12.00       28,535     03/2019 – 07/2020     12.00  
$ 14.10       10,000     03/2021     14.10  
$ 15.30       1,373     09/2018     15.30  
$ 16.50       262,441     03/2020     16.50  
$ 17.70       953     08/2016     17.70  
$ 24.00       4,667     12/2017     24.00  
$ 26.70       32,297     09/2017     26.70  
$ 28.80       11,767     04/2018     28.80  
$ 32.70       83,790     08/2017     32.70  
  Total       12,618,891         $ 0.83  
Schedule of share-based compensation warrants

The warrant activity for the period starting October 1, 2013, through June 30, 2015, is described as follows:

 

    Number of 
Shares		     Weighted Average 
Exercise Price		  
Outstanding at September 30, 2014     814,744     $ 3.07  
Granted     200,000       0.25  
Exercised     -       -  
Forfeited     (226,020 )     9.14  
Outstanding at December 31,2014     788,724     $ 0.61  
Granted     -       -  
Exercised     -       -  
Forfeited     (7,200 )     9.15  
Outstanding at March 31, 2015     781,524     $ 0.53  
Granted     -       -  
Exercised     -       -  
Forfeited     -       -  
Outstanding at June 30, 2015     781,524     $ 0.53  
Schedule of the status of warrants outstanding

Following is a summary of the status of warrants outstanding at June 30, 2015:

 

Exercise
Price		     Number
of Shares		     Expiration
Date		   Weighted Average
Exercise Price		  
                         
$ 0.04718       38,152     03/2018   $ 0.04718  
  0.25       332,200     04/2016 – 07/2017     0.25  
  0.275       324,000     06/2018 – 03/2019     0.275  
  1.00       67,170     10/2015 – 01/2017     1.00  
  7.50       3,334     05/2016     7.50  
$ 9.00       16,668     07/2017     9.00  
  Total       781,524         $ 0.53